期刊文献+

从患者依从性看门冬胰岛素30的临床疗效

Clinical Efficacy of Insulin Aspart 30 by Patient-Based Compliance
下载PDF
导出
摘要 患者的自我管理在糖尿病的治疗中意义重大,在我国当前的医疗条件下,选择一种依从性高的治疗方案,对于提高患者的自我管理水平,进而改善达标现状具有非常关键的作用。临床研究,门冬胰岛素30可全面降低血糖、安全性佳、治疗性价比高且注射方法简单,满足高依从性治疗方案的多项要求。 Patient-based compliance contributes to significance of diabetic therapeutics. In current medical conditions of China, choosing therapeutic strategy with high-compliance would play significant role in enforcing self-management and improving treat-to-target blood glucose management. Clinical trials indicated that, insulin aspart 30 achieved blood glucose control and excellent safety. Furthermore, high cost effectiveness and simply injection performance by insulin aspart 30 meet the need of high- compliance-based clinical therapeutic strategy.
作者 冯波 FENG Bo(Department of Endocrinology, East Hospital Affiliated to Tongji University, Shanghai 200120, China)
出处 《药品评价》 CAS 2016年第19期31-34,共4页 Drug Evaluation
关键词 糖尿病 门冬胰岛素30 临床疗效 依从性 Diabetes Insulin Aspart 30 Clinical Efficacy Patient-Based Compliance
  • 相关文献

参考文献8

二级参考文献116

共引文献1478

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部